SynthesisFrontiers in microbiology2025
Short-chain fatty acids and type 2 diabetes: a bibliometric analysis of knowledge structure, research hotspots, and future directions.
Synthesis in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Probiotic Modulation of Gut Microbiota: Antioxidant Mechanisms and Clinical Benefits in Obesity and Type 2 Diabetes Management.Antioxidants (Basel, Switzerland) · 2026Review
- Foods to Prevent Cardiometabolic Disease: Moving from "Saturated Fat" to "Whole Foods".Current developments in nutrition · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Type 2 diabetes mellitus (T2DM) is a public health challenge that urgently needs to be addressed globally. Short-chain fatty acids (SCFAs), as metabolic products of gut microbiota, have increasingly attracted attention for their role in the pathogenesis of T2DM. This study employs bibliometric and visual analysis methods, aiming to systematically depict the knowledge structure, research hotspots, and future directions in this field. Method: We screened 965 publications on SCFAs and T2DM from the Scopus and Web of Science Core Collection databases. Visual analysis was conducted by using tools such as VOSviewer and CiteSpace. Result: Since 2016 publications in this field have increased rapidly. China leads in publication volume, while the United States plays a central role in collaboration and academic influence. Key contributors include Max Nieuwdorp and Fredrik Bäckhed. King's College London shows strong academic impact, and Conclusions: The current research focuses on a deep exploration of the role and mechanism of SCFAs in T2DM, and it aims to transition from basic research to clinical research. In terms of application, clinical workers are shifting from macroscopic dietary intervention to more precise dietary formulation strategies. The development of technologies such as metabolomics is expected to provide more powerful support for basic research and promote further progress in this field.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.